A weekly newsletter for quality and training leaders in pharma and biotech.
The GxP Frame newsletter
Research and analysis on AI governance, workforce qualification, and GMP quality systems, sent when each new issue is published on gxpframe.com. Unsubscribe anytime.
FDA leaders announced a one-pivotal-trial policy direction with confirmatory evidence. Here is the case-by-case manufacturing readiness question it raises.
Lilly and Johnson & Johnson announced more than $4.5 billion in projects and over 1,350 planned jobs. Who will train and qualify the workforce?
FDA investigators identified cat hair during visual inspection and questioned the contamination investigation. What can quality teams review?